Detalhe da pesquisa
1.
COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022.
Euro Surveill
; 29(13)2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38551095
2.
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥â¯20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
Euro Surveill
; 28(47)2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37997666
3.
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥â¯20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
Euro Surveill
; 28(47)2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37997665
4.
Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021.
Euro Surveill
; 27(21)2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35620997
5.
Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021.
Euro Surveill
; 26(29)2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34296676